Showing results (101-110 of 319) with videos related to

Sort By:
Pageof 32
European Journal of Medicinal Chemistry|September 23, 2018
Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostatYu-Yi Chu-Farseeva, Nurulhuda Mustafa, Anders Poulsen, et al.
Cancer Research|February 19, 2021
SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple MyelomaPhyllis S Y Chong, Jing Yuan Chooi, Julia S L Lim, et al.
The Journal of Clinical Investigation|July 23, 2013
Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cellsAbdul Qader Omer Al-Aidaroos, Hiu Fung Yuen, Ke Guo, et al.
Cancer Medicine|October 16, 2023
Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myelomaKamlesh Bisht, Taro Fukao, Marielle Chiron, et al.
International Journal of Molecular Sciences|July 4, 2018
The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for TranslationSanjay de Mel, Gwyneth Shook-Ting Soon, Yingting Mok, et al.
Cancers|July 8, 2020
Natural History and Prognostic Factors at First Relapse in Multiple MyelomaChen Wang, Cinnie Yentia Soekojo, Sanjay de Mel, et al.
Cancer Cell International|August 29, 2020
Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma disseminationZhenhai Li, Shaji Kumar, Dong-Yan Jin, et al.
International Journal of Hematology|April 15, 2025
Treatment pathways and clinical outcomes in newly diagnosed multiple myeloma outside Europe and North America: The INTEGRATE studyKihyun Kim, Estelle Verburgh, Tatiana Mitina, et al.
Plos One|July 2, 2011
Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cellsZhigang Xie, Chonglei Bi, Lip Lee Cheong, et al.
Pageof 32